Mazdutide
A weight-loss peptide that hits two targets at once, in development by Innovent for obesity and type 2 diabetes.
Also listed as LY3305677, IBI362.
Peptide Compare tracked 11 vendors selling Mazdutide on 10 Oct 2026. The cheapest in-stock 10 mg vial is $7.00 per mg at NorthWest Peptides, 21% under the $8.90 median. Prices are scraped from vendor sites; trust scores come from Finnrick blind tests.
Some outbound links may earn us a commission. Vendors cannot pay to improve rankings.
Best value right now · 10 mg
NP
NorthWest Peptides
IN STOCKUNTESTED
Per mg21% under the $8.90 median
Vial price10 mg · verified Oct 10
Avg per mg · 10 mg
$17.14+144.9%
Ranged $7.00 – $39.49 across 11 vendorsCompare 8 vendors · 10 mg
Across all sizes, verified in-stock listings run $34.99 to $149.99 from 7 vendors.
VendorStock
07
PeptidologyTRUST 7.6 · OUT
$8.00$79.99
08
Welli LabsUNTESTED · OUT
$71.99$719.91
Mazdutide prices verified Oct 10, 2026
$7.00/mgNorthWest Peptides · $69.99
Buy best priceSee how Mazdutide moved against the rest of the catalogue in the Peptide Price Index: median price per mg now versus 30 and 90 days ago, every tracked peptide, with a CSV.
Mazdutide price by vial size
| Vial size | Lowest per mg | Vial price | Vendor |
|---|---|---|---|
| 5 mg | $7.00 | $34.99 | Eros Peptides2 vendors carry it |
| 10 mg | $7.00 | $69.99 | NorthWest Peptides8 vendors carry it |
| Other | $15.00 | $89.99 | AMC Essentials3 vendors carry it |
Verified 10 Oct 2026. Lowest figures are in-stock listings checked within the last week, with any coupon applied; a size with none says so.
Price movement · 30 days
0%median per mg, all sizes
Cheapest ever recorded: $4.95/mg on Sep 6. Today is 41.4% above that low.See our top-ranked Mazdutide vendors
Ranked by Finnrick trust score, independent lab testing, and price.
Compare Mazdutide head-to-head
- Mazdutide vs Retatrutide
- Mazdutide vs Tirzepatide
- Mazdutide vs Semaglutide
- Mazdutide vs Cagrilintide
- Mazdutide vs AOD-9604
- Mazdutide vs 5-Amino-1MQ
Quick Summary
A dual GLP-1 and glucagon receptor agonist developed by Innovent and Eli Lilly, approved in China and studied for weight management. Available from 11 vendors, priced from $34.99 to $719.91.
Research: GLORY-2 (JAMA 2026, PMID 42251595) is the Phase 3 trial: 461 participants on 9 mg for 60 weeks, mean weight change 16.65% (95% CI 15.12 to 18.19). The 20.1% figure once quoted here belongs to an unrelated Phase 1 trial of a 16 mg dose (PMID 40832785). The head-to-head DREAMS-3 trial (NCT06184568) is completed with no results posted, so the comparison against semaglutide that used to appear here has been removed.
Side effects: No adverse event rates were verified against the trial report for this page
Approved in ChinaApproved by China's NMPA. Not approved by the FDA or the EMA.
- 7 of 11 vendors currently have it in stock
- Highest-rated vendor: Peptidology (7.6 Finnrick score)
- Most common vial size: 10mg
- Category: Weight Loss (GLP-1) — GLP-1 receptor agonists for weight management
Get Mazdutide price alerts
Join the list — price-drop alerts for this peptide are in the works and you'll be first on them.